Literature DB >> 11756609

A sporadic case of rippling muscle disease caused by a de novo caveolin-3 mutation.

M Vorgerd1, K Ricker, F Ziemssen, W Kress, H H Goebel, W A Nix, C Kubisch, B G Schoser, W Mortier.   

Abstract

OBJECTIVE: To determine the cause of sporadic rippling muscle disease (RMD) in a 24-year-old patient.
BACKGROUND: RMD is a rare myopathy characterized by percussion-induced rapid muscle contractions (PIRC), muscle mounding, and rippling waves. We have recently found that autosomal dominant RMD is caused by mutations in the caveolin-3 gene (CAV3) on chromosome 3p25. Possibly, increased activity of neuronal nitric oxide synthase (nNOS) contributes to the clinical characteristics of increased mechanical muscle hyperexcitability.
METHODS: Clinical examination, mutational analysis, and immunohistochemistry of muscle tissue were performed in a patient with sporadic RMD.
RESULTS: The authors observed a de novo CAV3 missense mutation Arg26Gln. Immunohistochemistry showed reduced caveolin-3 surface expression in a muscle biopsy. In addition, the authors found normal sarcolemmal nNOS expression and a reduced expression of alpha-dystroglycan in muscle fibers.
CONCLUSIONS: These data confirm that RMD is caused by CAV3 mutations. Moreover, there is evidence that CAV3 mutations may also be found in patients without a positive family history of RMD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11756609     DOI: 10.1212/wnl.57.12.2273

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  8 in total

1.  Differential effects of myopathy-associated caveolin-3 mutants on growth factor signaling.

Authors:  Eva Brauers; Agnes Dreier; Andreas Roos; Berthold Wormland; Joachim Weis; Alexander Krüttgen
Journal:  Am J Pathol       Date:  2010-05-14       Impact factor: 4.307

2.  Novel mechanism for sudden infant death syndrome: persistent late sodium current secondary to mutations in caveolin-3.

Authors:  Lisa B Cronk; Bin Ye; Toshihiko Kaku; David J Tester; Matteo Vatta; Jonathan C Makielski; Michael J Ackerman
Journal:  Heart Rhythm       Date:  2006-12-06       Impact factor: 6.343

Review 3.  Caveolae as plasma membrane sensors, protectors and organizers.

Authors:  Robert G Parton; Miguel A del Pozo
Journal:  Nat Rev Mol Cell Biol       Date:  2013-02       Impact factor: 94.444

4.  Deletion of Cavin/PTRF causes global loss of caveolae, dyslipidemia, and glucose intolerance.

Authors:  Libin Liu; Dennis Brown; Mary McKee; Nathan K Lebrasseur; Dan Yang; Kenneth H Albrecht; Katya Ravid; Paul F Pilch
Journal:  Cell Metab       Date:  2008-10       Impact factor: 27.287

Review 5.  Caveolinopathies: from the biology of caveolin-3 to human diseases.

Authors:  Elisabetta Gazzerro; Federica Sotgia; Claudio Bruno; Michael P Lisanti; Carlo Minetti
Journal:  Eur J Hum Genet       Date:  2009-07-08       Impact factor: 4.246

Review 6.  RNAi-based gene therapy for dominant Limb Girdle Muscular Dystrophies.

Authors:  Jian Liu; Scott Q Harper
Journal:  Curr Gene Ther       Date:  2012-08       Impact factor: 4.391

7.  Biochemical and pathological changes result from mutated Caveolin-3 in muscle.

Authors:  José Andrés González Coraspe; Joachim Weis; Mary E Anderson; Ute Münchberg; Kristina Lorenz; Stephan Buchkremer; Stephanie Carr; René Peiman Zahedi; Eva Brauers; Hannah Michels; Yoshihide Sunada; Hanns Lochmüller; Kevin P Campbell; Erik Freier; Denisa Hathazi; Andreas Roos
Journal:  Skelet Muscle       Date:  2018-08-28       Impact factor: 4.912

8.  Identification and functional analysis of a new putative caveolin-3 variant found in a patient with sudden unexplained death.

Authors:  Vincenzo Lariccia; Annamaria Assunta Nasti; Federica Alessandrini; Mauro Pesaresi; Santo Gratteri; Adriano Tagliabracci; Salvatore Amoroso
Journal:  J Biomed Sci       Date:  2014-06-10       Impact factor: 8.410

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.